Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Plain language summary
“Switching between TNFi drugs for patients with axial spondyloarthritis”
Plain language summary of the scientific publication from EuroSpA: “Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching” by Linde et. al.
You can read the original article published in Rheumatology in 2023 here: https://doi.org/10.1093/rheumatology/kead494
